110 related articles for article (PubMed ID: 17400210)
1. Inhibition of ErbB2/neuregulin signaling augments paclitaxel-induced cardiotoxicity in adult ventricular myocytes.
Pentassuglia L; Timolati F; Seifriz F; Abudukadier K; Suter TM; Zuppinger C
Exp Cell Res; 2007 May; 313(8):1588-601. PubMed ID: 17400210
[TBL] [Abstract][Full Text] [Related]
2. Modulation of anthracycline-induced myofibrillar disarray in rat ventricular myocytes by neuregulin-1beta and anti-erbB2: potential mechanism for trastuzumab-induced cardiotoxicity.
Sawyer DB; Zuppinger C; Miller TA; Eppenberger HM; Suter TM
Circulation; 2002 Apr; 105(13):1551-4. PubMed ID: 11927521
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of ErbB2 by receptor tyrosine kinase inhibitors causes myofibrillar structural damage without cell death in adult rat cardiomyocytes.
Pentassuglia L; Graf M; Lane H; Kuramochi Y; Cote G; Timolati F; Sawyer DB; Zuppinger C; Suter TM
Exp Cell Res; 2009 Apr; 315(7):1302-12. PubMed ID: 19331811
[TBL] [Abstract][Full Text] [Related]
4. Neuregulin-1 beta attenuates doxorubicin-induced alterations of excitation-contraction coupling and reduces oxidative stress in adult rat cardiomyocytes.
Timolati F; Ott D; Pentassuglia L; Giraud MN; Perriard JC; Suter TM; Zuppinger C
J Mol Cell Cardiol; 2006 Nov; 41(5):845-54. PubMed ID: 17005195
[TBL] [Abstract][Full Text] [Related]
5. Enhanced sensitization to taxol-induced apoptosis by herceptin pretreatment in ErbB2-overexpressing breast cancer cells.
Lee S; Yang W; Lan KH; Sellappan S; Klos K; Hortobagyi G; Hung MC; Yu D
Cancer Res; 2002 Oct; 62(20):5703-10. PubMed ID: 12384528
[TBL] [Abstract][Full Text] [Related]
6. Sublethal doses of an anti-erbB2 antibody leads to death by apoptosis in cardiomyocytes sensitized by low prosenescent doses of epirubicin: the protective role of dexrazoxane.
Spallarossa P; Altieri P; Pronzato P; Aloi C; Ghigliotti G; Barsotti A; Brunelli C
J Pharmacol Exp Ther; 2010 Jan; 332(1):87-96. PubMed ID: 19841470
[TBL] [Abstract][Full Text] [Related]
7. Anti-erbB2 treatment induces cardiotoxicity by interfering with cell survival pathways.
Pugatsch T; Abedat S; Lotan C; Beeri R
Breast Cancer Res; 2006; 8(4):R35. PubMed ID: 16839426
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of cardiotoxicity associated with ErbB2 inhibitors.
Fedele C; Riccio G; Malara AE; D'Alessio G; De Lorenzo C
Breast Cancer Res Treat; 2012 Jul; 134(2):595-602. PubMed ID: 22674190
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (paclitaxel)-induced cytotoxicity.
Menendez JA; Vellon L; Colomer R; Lupu R
Int J Cancer; 2005 May; 115(1):19-35. PubMed ID: 15657900
[TBL] [Abstract][Full Text] [Related]
10. Bigendothelin-1 via p38-MAPK-dependent mechanism regulates adult rat ventricular myocyte contractility in sepsis.
Gupta A; Aberle NS; Kapoor R; Ren J; Sharma AC
Biochim Biophys Acta; 2005 Jun; 1741(1-2):127-39. PubMed ID: 15955456
[TBL] [Abstract][Full Text] [Related]
11. Inactivation of the antiapoptotic phosphatidylinositol 3-kinase-Akt pathway by the combined treatment of taxol and mitogen-activated protein kinase kinase inhibition.
MacKeigan JP; Taxman DJ; Hunter D; Earp HS; Graves LM; Ting JP
Clin Cancer Res; 2002 Jul; 8(7):2091-9. PubMed ID: 12114408
[TBL] [Abstract][Full Text] [Related]
12. Cancer therapy modulates VEGF signaling and viability in adult rat cardiac microvascular endothelial cells and cardiomyocytes.
Chiusa M; Hool SL; Truetsch P; Djafarzadeh S; Jakob SM; Seifriz F; Scherer SJ; Suter TM; Zuppinger C; Zbinden S
J Mol Cell Cardiol; 2012 May; 52(5):1164-75. PubMed ID: 22326847
[TBL] [Abstract][Full Text] [Related]
13. A novel compound DT-010 protects against doxorubicin-induced cardiotoxicity in zebrafish and H9c2 cells by inhibiting reactive oxygen species-mediated apoptotic and autophagic pathways.
Tang F; Zhou X; Wang L; Shan L; Li C; Zhou H; Lee SM; Hoi MP
Eur J Pharmacol; 2018 Feb; 820():86-96. PubMed ID: 29229534
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of ErbB2 causes mitochondrial dysfunction in cardiomyocytes: implications for herceptin-induced cardiomyopathy.
Grazette LP; Boecker W; Matsui T; Semigran M; Force TL; Hajjar RJ; Rosenzweig A
J Am Coll Cardiol; 2004 Dec; 44(11):2231-8. PubMed ID: 15582322
[TBL] [Abstract][Full Text] [Related]
15. Cardioprotection induced by hydrogen sulfide preconditioning involves activation of ERK and PI3K/Akt pathways.
Hu Y; Chen X; Pan TT; Neo KL; Lee SW; Khin ES; Moore PK; Bian JS
Pflugers Arch; 2008 Jan; 455(4):607-16. PubMed ID: 17674030
[TBL] [Abstract][Full Text] [Related]
16. [Molecular mechanism of chemosensitization to paclitaxel in human melanoma cells induced by targeting the EGFR signaling pathway].
Zhang XJ; Zhang L; Liu YP; Xu HM; Sun P; Song JG; Luo YH
Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):181-6. PubMed ID: 23879997
[TBL] [Abstract][Full Text] [Related]
17. Potentiation of paclitaxel cytotoxicity in lung and esophageal cancer cells by pharmacologic inhibition of the phosphoinositide 3-kinase/protein kinase B (Akt)-mediated signaling pathway.
Nguyen DM; Chen GA; Reddy R; Tsai W; Schrump WD; Cole G; Schrump DS
J Thorac Cardiovasc Surg; 2004 Feb; 127(2):365-75. PubMed ID: 14762343
[TBL] [Abstract][Full Text] [Related]
18. Blockade of the erbB2 receptor induces cardiomyocyte death through mitochondrial and reactive oxygen species-dependent pathways.
Gordon LI; Burke MA; Singh AT; Prachand S; Lieberman ED; Sun L; Naik TJ; Prasad SV; Ardehali H
J Biol Chem; 2009 Jan; 284(4):2080-7. PubMed ID: 19017630
[TBL] [Abstract][Full Text] [Related]
19. Aqueous extract of Cortex Dictamni protects H9c2 cardiomyocytes from hypoxia/reoxygenation-induced oxidative stress and apoptosis by PI3K/Akt signaling pathway.
Li L; Zhou Y; Li Y; Wang L; Sun L; Zhou L; Arai H; Qi Y; Xu Y
Biomed Pharmacother; 2017 May; 89():233-244. PubMed ID: 28231545
[TBL] [Abstract][Full Text] [Related]
20. Tunicamycin potentiates paclitaxel-induced apoptosis through inhibition of PI3K/AKT and MAPK pathways in breast cancer.
Huang S; Wang D; Zhang S; Huang X; Wang D; Ijaz M; Shi Y
Cancer Chemother Pharmacol; 2017 Oct; 80(4):685-696. PubMed ID: 28779263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
